Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancers|July 14, 2023
Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort StudyMatteo Conti, Elena Bolzacchini, Giovanna Luchena, et al.
Clinical Lung Cancer|May 10, 2011
Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor receptor mutationsGabriella Farina, Flavia Longo, Olga Martelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2018
CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung CancerThanyanan Reungwetwattana, Kazuhiko Nakagawa, Byoung Chul Cho, et al.
Scientific Reports|November 18, 2015
Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)Monica Ganzinelli, Eliana Rulli, Elisa Caiola, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 5, 2010
The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational studyDaniele Fagnani, Alessandro Bertolini, Laura Catena, et al.
The Review of Scientific Instruments|April 3, 2016
Characterization of the room temperature payload prototype for the cryogenic interferometric gravitational wave detector KAGRAFabián Erasmo Peña Arellano, Takanori Sekiguchi, Yoshinori Fujii, et al.
Plos One|November 9, 2013
Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis surveyNicola Silvestris, Francesco Pantano, Toni Ibrahim, et al.
JCO Precision Oncology|June 12, 2026
Liquid Biopsy Monitoring in BRAF V600E-Mutated Patients With Non-Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020)Alessandro Leonetti, Monica Pluchino, Roberta Minari, et al.
Targeted Oncology|March 28, 2018
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss StudyMaria Di Bartolomeo, Monica Niger, Giuseppe Tirino, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trialMarco Platania, Felice Pasini, Luca Porcu, et al.
Pageof 3